Novo Nordisk Bets $506M on Ireland Expansion to Counter Eli Lilly Competition
Danish pharmaceutical giant Novo Nordisk is investing €432 million ($506 million) in its Athlone facility in Ireland to expand production
Eli Lilly to Spend $3.5 Billion on New U.S. Plant for Next-Gen Obesity Drugs
Eli Lilly is doubling down on its push to dominate the fast-growing obesity drug market. The pharmaceutical giant announced plans
Eli Lilly Makes History: How a Weight-Loss Shot Pushed a Drugmaker to the Trillion-Dollar Club
For the first time in history, a health-care company has stepped into a territory once reserved almost entirely for the
The Blockbuster Weight-Loss Drug Market: What’s Driving the Boom and What’s Next
The Market So Far The weight-loss drug market is growing fast, and the next chapter is already starting. At the
Trump Says Ozempic Should Cost $150 — Big Pharma’s Billion-Dollar Secret Just Got Exposed
Trump Just Blew the Lid Off the Weight-Loss Drug Industry — And Wall Street Is Losing Its Mind In a